(2025). Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025. MMWR Morbidity and Mortality Weekly Report.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025."
MMWR Morbidity and Mortality Weekly Report 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025."
MMWR Morbidity and Mortality Weekly Report, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.